Purchase Order 75N95024P00370
Award Date
6/28/24
Potential Completion Date
6/27/25
Potential Value
$19K
Federal Agency
National Institute on Drug Abuse
Awardee
Revvity Health Sciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Revvity Health Sciences, Inc. for the delivery of a HTRF GTP GI Bind. Kit - 20K PTS to the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract has a firm fixed price of $20,727.50 and a period of performance through November 29, 2024. This award is not associated with a set-aside program. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $80,650.96 firm fixed price purchase order contract to Revvity Health Sciences, Inc. for the procurement of a MicroBeta2 plate reader and a cell harvester. The contract has a period of performance through July 29, 2021. This purchase supports NIDA's research and development efforts in brain receptor imaging and investigating promising compounds. The award did not utilize any small business set-aside. Revvity Health...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $17,185 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to deliver 100,000 points worth of HTRF CAMP GI KIT assay kits. The kits will support drug abuse research programs at the National Institute on Drug Abuse. Delivery of the assay kits will take place in Baltimore, Maryland over the course of a one year ordering period. No subcontractors or...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $915,668.54, is for the delivery of unspecified medical imaging products and services to NIDA. The award is not set aside for small businesses. As a prime contractor, Revvity Health Sciences has provided a variety of medical devices...
This firm fixed-price delivery order was awarded to Revvity Health Sciences, Inc. by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. federal government. The contract, valued at $106,514.11, is for the provision of a MicroBeta 2 plate reader with 6 detectors. It was awarded under the General Services Administration's (GSA) Scientific Equipment and Services schedule (FSS-66) and does not utilize any set-aside designation. Revvity Health Sciences is a for-profit...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is valued at $10,652.49 and has a period of performance from April 24, 2024 to April 23, 2025. The contract does not have a set-aside designation. Revvity Health Sciences has a history of providing a variety...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 26, 2016. The contract has a ceiling value of $320,095.60 and a completion date of January 30, 2017. The contract was not set aside for any specific business type. Revvity Health Sciences, a for-profit manufacturer, will provide medical...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $373,274.40 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for a preclinical in-vivo optical imaging system for the NIH Mouse Imaging Facility (MIF). The contract was awarded on September 19, 2019, with a completion date of September 18, 2020. Revvity Health Sciences, Inc. is a for-profit organization and manufacturer of medical imaging products and...
The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a $101,599.04 firm fixed-price purchase order to Revvity Health Sciences, Inc. to provide COVID-19 related equipment and reagents. The award has a Coronavirus COVID-19 National Interest Action Code and was completed on April 10, 2020, shortly after the initial contract award on April 6, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit...
This is a $214,952.40 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit medical imaging equipment manufacturer. The contract is for the delivery of unspecified laboratory products and services to support research initiatives at the NIH facility in Bethesda, Maryland. This contract does not have a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the...